What are Peptide drugs?

Peptide drugs are pharmacologic agents that share a common mechanism (typically targeting Tumor vasculature). 0 are currently marketed, with 2 more in clinical development.

Peptide

0 marketed 1 in Phase 2 1 in Phase 1

This page covers all Peptide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tumor vasculature, alpha-synuclein.

Targets

Tumor vasculature · alpha-synuclein

Phase 2 pipeline (1)

EndoTAG-1 and Gemcitabine · MediGene · Oncology
EndoTAG-1 is a peptide that targets the tumor vasculature, while Gemcitabine is a nucleoside analog that interferes with DNA synthesis.

Phase 1 pipeline (1)

AFFITOPE® PD01A · Affiris AG · Neurology
AFFITOPE® PD01A is designed to induce an immune response against alpha-synuclein, a protein implicated in Parkinson's disease.